Latest Administration News

TrivarX has moved Stabl-Im closer to human testing, with pre-clinical studies underway, investigational product preparation progressing and clinical site selection now open. The indicative plan targets first participant enrolment in Q1 2027, but key technical and ethics steps remain outstanding.

Perpetual Resources has added 62 lode claims around its Nevada Scheelite tungsten project, expanding the land position by 1,271.63 acres and more than 15 times the original patented claim area. The move broadens the project from a historic mine redevelopment opportunity into a larger exploration play, although the new ground remains untested.

Patrys has dosed the first participants in the Phase 1a trial of RLS-2202, moving its intravenous quetiapine formulation into human clinical evaluation. The next test comes in October, when an independent safety committee will decide whether the program can advance to Cohort 2.

Eminence Minerals has begun field exploration across three pending licence applications at its Tayra rare earth project in Bahia, Brazil, while continuing a planned 70-hole auger campaign at Campo Grande. The work remains early-stage, with no Mineral Resource defined and Tayra’s tenure still awaiting confirmation from Brazil’s mining regulator.

AdAlta has secured a formal US FDA pre-IND meeting for EW-001, moving its mesothelioma CAR-T therapy into a critical regulatory review. The November meeting will test the company’s Australian manufacturing, remaining studies and proposed Phase 1 trial before the more expensive stages of development begin.

Medallion Metals has shifted from project preparation to execution, with Ravensthorpe fully permitted, Forrestania acquired and Cosmic Boy refurbishment underway. The transition is funded by cash, equity and a US$50 million Trafigura facility, but production delivery and rehabilitation liabilities remain substantial tests.

Finbar Group (ASX:FRI) delivered its strongest annual profit since FY2015, with net profit rising 40.9% to $20.3 million despite lower revenue. Record pre-sales, reduced debt and a $1.95 billion development pipeline give the Perth apartment developer a substantial FY27 workload.

PC Gold’s Spring Hill project emerged from FY2026 with a sharply larger resource, fresh institutional funding and a clearer path towards feasibility studies. The gold explorer remains pre-production and loss-making, but its post-year-end A$75 million raise gives it substantial room to expand drilling and development work.

Firetrail S3 Global Opportunities Fund (Managed Fund) (ASX:S3GO) delivered a 14.07% pre-fee return in the year to 30 June 2026, beating its MSCI World benchmark by 3.69 percentage points. Net assets rose to $36.471 million despite substantial net redemptions during the year.

CAR Group has confirmed a DRP price of AUD 23.651 for its 43.5-cent ordinary dividend, payable on 12 October. The distribution is 30% franked and will be issued at no discount to participating shareholders.

Tanami Gold has entered FY27 with funding in place for a 3,500-metre underground decline at Groundrush, after raising $70.5 million and reporting a 2.8 million ounce Central Tanami resource. The project remains in the study and resource-definition phase, with no Ore Reserve or production decision yet disclosed.

AngloGold Ashanti has exercised early an option to acquire specified Lake Carey tenements from Matsa Resources for a fixed A$55 million, although most of the consideration remains conditional. The deal arrives as Matsa refinances existing debt, manages an operational review and remains suspended from trading.